Low-intensity pulsed ultrasound increases cellular uptake of superparamagnetic iron oxide nanomaterial: Results from human osteosarcoma cell line U2OS

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 6, 2010, Pages 1508-1513

  Wang, Yi Xiang J ^a   Leung, Ken Cham Fai ^b   Cheung, Wing Hoi ^a   Wang, Hao Hao ^a,c   Shi, Lin ^a   Wang, De Feng ^b   Qin, Ling ^a   Ahuja, Anil T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell labeling; Magnetic resonance imaging; Prussian blue staining; Superparamagnetic iron oxide; Ultrasound

Indexed keywords

FERRIC FERROCYANIDE; NANOMATERIAL; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; FERRIC ION; FERRIC OXIDE; FERROCYANIDE;

ARTICLE; CELL LABELING; ENDOCYTOSIS; FRACTURE HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA CELL; PRIORITY JOURNAL; ULTRASOUND; CHEMISTRY; DOSE RESPONSE; ECHOGRAPHY; NANOTECHNOLOGY; PROCEDURES; TUMOR CELL LINE;

CELL LINE, TUMOR; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; FERRIC COMPOUNDS; FERROCYANIDES; HUMANS; MAGNETIC RESONANCE IMAGING; NANOSTRUCTURES; NANOTECHNOLOGY; ULTRASONICS; ULTRASONOGRAPHY;

EID: 77952843594     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22173     Document Type: Article

References (29)

1. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331. (Pubitemid 33041104)
2. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006;58:1471-1504. (Pubitemid 44820503)
3. Tang TY, Howarth SP, Miller SR, et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol 2009;53:2039-2050.
4. Leung KC, Wang YX, Wang H, Xuan S, Chak CP, Cheng CH. Biological and magnetic contrast evaluation of shape-selective Mn-Fe nanowires. IEEE Trans Nanobiosci 2009;8:192-198.
5. Arbab AS, Yocum GT, Rad AM, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553-559. (Pubitemid 43013896)
6. Schäfer R, Kehlbach R, Müller M, et al. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 2009;11:68-78.
7. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling of with ferumoxides. Blood 2004;104:3410-3412.
8. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487.
9. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003;76:1123-1130.
10. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med 2006;3:554-562.
11. Daldrup-Link HE, Meier R, Rudelius M, et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 2005;15:4-13.
12. Strand BL, Ryan TL, In't Veld P, et al. Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 2001;10:263-275.
13. Dinno MA, Dyson M, Young SR, Mortimer AJ, Hart J, Crum LA. The significance of membrane changes in the safe and effective use of therapeutic and diagnostic ultrasound. Phys Med Biol 1989;34:1543-1552. (Pubitemid 19265762)
14. Chumakova OV, Liopo AV, Andreev VG, et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett 2008;261:215-225.
15. Liu J, Lewis TN, Prausnitz MR. Non-invasive assessment and control of ultrasound-mediated membrane permeabilization. Pharm Res 1998;15:918-924. (Pubitemid 28307835)
16. Rubin C, Bolander M, Ryaby JP, Hadjiargyrou M. The use of low-intensity ultrasound to accelerate the healing of fractures. J Bone Joint Surg Am 2001;83:259-270. (Pubitemid 32163721)
17. Wang HH, Wang YX, Leung KCF, et al. Mesenchymal stem cell intracellular labeling using silica-coated superparamagnetic iron oxide nanoparticles with amine functional peripheries. In: 2008 IEEE International Special Topic Conference on Information Technology and Applications in Biomedicine. Vols. 1 and 2. p 274-276.
18. Wang HH, Wang YX, Leung KCF, et al. Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Chem Eur J 2009;15:12417-12425.
19. Tam KF, Cheung WH, Lee KM, Qin L, Leung KS. Osteogenic effects of low-intensity pulsed ultrasound, extracorporeal shock-waves and their combination-an in vitro comparative study on human periosteal cells. Ultrasound Med Biol 2008;34:1957-1965.
20. Leung KS, Lee WS, Tsui HF, Liu PP, Cheung WH. Complex tibial fracture outcomes following treatment with low-intensity pulsed ultrasound. Ultrasound Med Biol 2004;30:389-395. (Pubitemid 38456706)
21. Nolte PA, Klein-Nulend J, Albers GH, et al. Low-intensity ultrasound stimulates endochondral ossification in vitro. J Orthop Res 2001;19:301-307. (Pubitemid 32331707)
22. Koh S. The safety of diagnostic continuous wave ultrasonic irradiation - a clinical study serum hemoglobulin level and scanning electron microscopic finding of maternal and cord blood in vitro [in Japanese]. Acta Obstet Gynaecol Jpn 1981;33:469-478. (Pubitemid 11074836)
23. Yoon JH, Roh EY, Shin S, et al. Introducing pulsed low-intensity ultrasound to culturing human umbilical cord-derived mesenchymal stem cells. Biotechnol Lett 2009;31:329-335.
24. Lee HJ, Choi BH, Min BH, Park SR. Low-intensity ultrasound inhibits apoptosis and enhances viability of human mesenchymal stem cells in three-dimensional alginate culture during chondrogenic differentiation. Tissue Eng 2007;13:1049-1057.
25. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-1858. (Pubitemid 39386634)
26. Wang YX. Comments on Jing et al. original article "In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection." Joint Bone Spine 2009;76:118-119.
27. Wang YX, Wang HH, Au DWT, Zuo BS, Teng LS. Pitfalls in employing superparamagnetic iron oxide particles for stem cell labeling and in vivo MRI tracking. Br J Radiol 2008;81:987-988.
28. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004;17:513-517. (Pubitemid 39549429)
29. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stemcells is inhibited after magnetic labeling of with ferumoxides. Blood 2004;104:3410-3412.